Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

A measure of growth - but companies need to be more forthcoming with market and sales data

This article was originally published in Clinica

Executive Summary

Devices and diagnostics are growth markets; that much is sure. The top 20 companies show impressive high single-digit or mid- high-teens sales growth year-on-year...take for example at 2003 year-end Becton Dickinson +12% to $4.5bn, Fresenius +9% to $4.1bn and J&J +18.5% to $14.9bn. And after nine months GEMS +11%, Guidant +20%, Stryker +20%, Baxter +9%, Boston +21%, Zimmer +20%, etc....They measure up well in terms of sales performance quarter by quarter, and it's easy to track where the gains are being made.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT057298

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel